Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer

NCT: NCT03121469 · COMPLETED

NCT IDNCT03121469
StatusCOMPLETED
Start Date2018-10-25
Completion2025-06-10
SponsorCentre Antoine Lacassagne (OTHER)
First posted
Last updated

Brief Summary

Phase 1/2 study, open, monocenter, non-randomized

Frequently Asked Questions

What is Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer?

Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer is a clinical trial registered under NCT03121469. Current status: COMPLETED.

What is the status of NCT03121469?

The current status of NCT03121469 (Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer) is: COMPLETED.

When did Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer start?

Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer started on 2018-10-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑